nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—TNF—Graves' disease	0.737	1	CbGaD
Pseudoephedrine—Epigastric distress—Methimazole—Graves' disease	0.0149	0.298	CcSEcCtD
Pseudoephedrine—Epigastric distress—Propylthiouracil—Graves' disease	0.0127	0.253	CcSEcCtD
Pseudoephedrine—CYP2D6—Methimazole—Graves' disease	0.0125	1	CbGbCtD
Pseudoephedrine—NFATC1—connective tissue—Graves' disease	0.00587	0.181	CbGeAlD
Pseudoephedrine—IL2—connective tissue—Graves' disease	0.00537	0.166	CbGeAlD
Pseudoephedrine—NFATC1—adipose tissue—Graves' disease	0.0045	0.139	CbGeAlD
Pseudoephedrine—NFATC1—thyroid gland—Graves' disease	0.0039	0.12	CbGeAlD
Pseudoephedrine—IL2—thyroid gland—Graves' disease	0.00356	0.11	CbGeAlD
Pseudoephedrine—Vertigo—Methimazole—Graves' disease	0.00227	0.0454	CcSEcCtD
Pseudoephedrine—Vertigo—Propylthiouracil—Graves' disease	0.00193	0.0386	CcSEcCtD
Pseudoephedrine—Dyspepsia—Methimazole—Graves' disease	0.00182	0.0363	CcSEcCtD
Pseudoephedrine—Body temperature increased—Methimazole—Graves' disease	0.00163	0.0326	CcSEcCtD
Pseudoephedrine—Dyspepsia—Propylthiouracil—Graves' disease	0.00155	0.0308	CcSEcCtD
Pseudoephedrine—Body temperature increased—Propylthiouracil—Graves' disease	0.00139	0.0277	CcSEcCtD
Pseudoephedrine—ADRB1—connective tissue—Graves' disease	0.00135	0.0416	CbGeAlD
Pseudoephedrine—Vomiting—Methimazole—Graves' disease	0.00131	0.0262	CcSEcCtD
Pseudoephedrine—Rash—Methimazole—Graves' disease	0.0013	0.026	CcSEcCtD
Pseudoephedrine—Dermatitis—Methimazole—Graves' disease	0.0013	0.026	CcSEcCtD
Pseudoephedrine—Headache—Methimazole—Graves' disease	0.00129	0.0258	CcSEcCtD
Pseudoephedrine—Nausea—Methimazole—Graves' disease	0.00123	0.0245	CcSEcCtD
Pseudoephedrine—Vomiting—Propylthiouracil—Graves' disease	0.00112	0.0223	CcSEcCtD
Pseudoephedrine—Rash—Propylthiouracil—Graves' disease	0.00111	0.0221	CcSEcCtD
Pseudoephedrine—Dermatitis—Propylthiouracil—Graves' disease	0.00111	0.0221	CcSEcCtD
Pseudoephedrine—Headache—Propylthiouracil—Graves' disease	0.0011	0.0219	CcSEcCtD
Pseudoephedrine—MAOA—connective tissue—Graves' disease	0.00105	0.0326	CbGeAlD
Pseudoephedrine—Nausea—Propylthiouracil—Graves' disease	0.00104	0.0208	CcSEcCtD
Pseudoephedrine—ADRB1—adipose tissue—Graves' disease	0.00103	0.0319	CbGeAlD
Pseudoephedrine—ADRA1A—adipose tissue—Graves' disease	0.000816	0.0252	CbGeAlD
Pseudoephedrine—MAOA—pituitary gland—Graves' disease	0.000812	0.0251	CbGeAlD
Pseudoephedrine—MAOA—adipose tissue—Graves' disease	0.000809	0.025	CbGeAlD
Pseudoephedrine—ADRA2A—connective tissue—Graves' disease	0.000809	0.025	CbGeAlD
Pseudoephedrine—NFATC1—Downstream signaling in naïve CD8+ T cells—IFNG—Graves' disease	0.000726	0.00432	CbGpPWpGaD
Pseudoephedrine—IL2—IL2-mediated signaling events—IFNG—Graves' disease	0.000721	0.00429	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.000703	0.00419	CbGpPWpGaD
Pseudoephedrine—MAOA—thyroid gland—Graves' disease	0.0007	0.0216	CbGeAlD
Pseudoephedrine—NFATC1—AP-1 transcription factor network—IFNG—Graves' disease	0.000693	0.00413	CbGpPWpGaD
Pseudoephedrine—IL2—SHP2 signaling—IFNG—Graves' disease	0.000681	0.00406	CbGpPWpGaD
Pseudoephedrine—IL2—Glucocorticoid receptor regulatory network—ICAM1—Graves' disease	0.000679	0.00404	CbGpPWpGaD
Pseudoephedrine—IL2—IL12-mediated signaling events—IFNG—Graves' disease	0.000663	0.00395	CbGpPWpGaD
Pseudoephedrine—IL2—IL12-mediated signaling events—CD4—Graves' disease	0.00064	0.00381	CbGpPWpGaD
Pseudoephedrine—TNF—Cytokines and Inflammatory Response—HLA-DRB1—Graves' disease	0.00064	0.00381	CbGpPWpGaD
Pseudoephedrine—IL2—IL23-mediated signaling events—TNF—Graves' disease	0.000632	0.00376	CbGpPWpGaD
Pseudoephedrine—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—FASLG—Graves' disease	0.000629	0.00375	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by Interleukins—IL2RA—Graves' disease	0.000628	0.00374	CbGpPWpGaD
Pseudoephedrine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Graves' disease	0.000624	0.00372	CbGpPWpGaD
Pseudoephedrine—ADRA2A—pituitary gland—Graves' disease	0.000623	0.0193	CbGeAlD
Pseudoephedrine—ADRA2A—adipose tissue—Graves' disease	0.000621	0.0192	CbGeAlD
Pseudoephedrine—IL2—Downstream signaling in naïve CD8+ T cells—IFNG—Graves' disease	0.000614	0.00366	CbGpPWpGaD
Pseudoephedrine—IL2—Folate Metabolism—IFNG—Graves' disease	0.000614	0.00366	CbGpPWpGaD
Pseudoephedrine—NFATC1—Glucocorticoid receptor regulatory network—IFNG—Graves' disease	0.000611	0.00364	CbGpPWpGaD
Pseudoephedrine—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—FAS—Graves' disease	0.000607	0.00361	CbGpPWpGaD
Pseudoephedrine—IL2—Regulation of Telomerase—IFNG—Graves' disease	0.0006	0.00357	CbGpPWpGaD
Pseudoephedrine—IL2—IL12-mediated signaling events—IL1B—Graves' disease	0.000591	0.00352	CbGpPWpGaD
Pseudoephedrine—NFATC1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.000587	0.0035	CbGpPWpGaD
Pseudoephedrine—IL2—AP-1 transcription factor network—IFNG—Graves' disease	0.000586	0.00349	CbGpPWpGaD
Pseudoephedrine—IL2—Folate Metabolism—IL1B—Graves' disease	0.000548	0.00326	CbGpPWpGaD
Pseudoephedrine—NFATC1—TCR Signaling Pathway—CD4—Graves' disease	0.000547	0.00326	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—FASLG—Graves' disease	0.000544	0.00324	CbGpPWpGaD
Pseudoephedrine—ADRA2A—thyroid gland—Graves' disease	0.000537	0.0166	CbGeAlD
Pseudoephedrine—TNF—amb2 Integrin signaling—ICAM1—Graves' disease	0.000536	0.00319	CbGpPWpGaD
Pseudoephedrine—IL2—Allograft Rejection—IFNG—Graves' disease	0.000532	0.00317	CbGpPWpGaD
Pseudoephedrine—IL2—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	0.000531	0.00316	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—FAS—Graves' disease	0.000524	0.00312	CbGpPWpGaD
Pseudoephedrine—TNF—FAS pathway and Stress induction of HSP regulation—FASLG—Graves' disease	0.000519	0.00309	CbGpPWpGaD
Pseudoephedrine—IL2—Glucocorticoid receptor regulatory network—IFNG—Graves' disease	0.000516	0.00307	CbGpPWpGaD
Pseudoephedrine—IL2—Spinal Cord Injury—ICAM1—Graves' disease	0.000507	0.00302	CbGpPWpGaD
Pseudoephedrine—NFATC1—TCR Signaling Pathway—IL1B—Graves' disease	0.000506	0.00301	CbGpPWpGaD
Pseudoephedrine—TNF—FAS pathway and Stress induction of HSP regulation—FAS—Graves' disease	0.0005	0.00298	CbGpPWpGaD
Pseudoephedrine—IL2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.000497	0.00296	CbGpPWpGaD
Pseudoephedrine—TNF—Cellular roles of Anthrax toxin—IL1B—Graves' disease	0.000491	0.00292	CbGpPWpGaD
Pseudoephedrine—TNF—IL27-mediated signaling events—IFNG—Graves' disease	0.000482	0.00287	CbGpPWpGaD
Pseudoephedrine—IL2—Allograft Rejection—IL1B—Graves' disease	0.000475	0.00283	CbGpPWpGaD
Pseudoephedrine—NFATC1—Downstream signaling in naïve CD8+ T cells—TNF—Graves' disease	0.00047	0.0028	CbGpPWpGaD
Pseudoephedrine—TNF—Cytokines and Inflammatory Response—IFNG—Graves' disease	0.000467	0.00278	CbGpPWpGaD
Pseudoephedrine—TNF—Cytokines and Inflammatory Response—CD4—Graves' disease	0.000451	0.00269	CbGpPWpGaD
Pseudoephedrine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—Graves' disease	0.000451	0.00269	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—HLA-E—Graves' disease	0.000449	0.00268	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—CD40—Graves' disease	0.000439	0.00262	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—HLA-E—Graves' disease	0.000439	0.00261	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—CTLA4—Graves' disease	0.000433	0.00258	CbGpPWpGaD
Pseudoephedrine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Graves' disease	0.000433	0.00258	CbGpPWpGaD
Pseudoephedrine—TNF—IL27-mediated signaling events—IL1B—Graves' disease	0.00043	0.00256	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Monoamine Transport—IL1B—Graves' disease	0.000421	0.00251	CbGpPWpGaD
Pseudoephedrine—TNF—Cytokines and Inflammatory Response—IL1B—Graves' disease	0.000417	0.00248	CbGpPWpGaD
Pseudoephedrine—TNF—Caspase Cascade in Apoptosis—FASLG—Graves' disease	0.000406	0.00242	CbGpPWpGaD
Pseudoephedrine—MAOA—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000406	0.00242	CbGpPWpGaD
Pseudoephedrine—IL2—Downstream signaling in naïve CD8+ T cells—TNF—Graves' disease	0.000398	0.00237	CbGpPWpGaD
Pseudoephedrine—IL2—Folate Metabolism—TNF—Graves' disease	0.000398	0.00237	CbGpPWpGaD
Pseudoephedrine—TNF—Caspase Cascade in Apoptosis—FAS—Graves' disease	0.000392	0.00233	CbGpPWpGaD
Pseudoephedrine—IL2—Spinal Cord Injury—IFNG—Graves' disease	0.000386	0.0023	CbGpPWpGaD
Pseudoephedrine—TNF—Downstream signaling in naïve CD8+ T cells—CD8A—Graves' disease	0.000384	0.00229	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000377	0.00225	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—IFIH1—Graves' disease	0.00037	0.0022	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by Interleukins—IL1B—Graves' disease	0.00037	0.0022	CbGpPWpGaD
Pseudoephedrine—TNF—Vitamin B12 Metabolism—ICAM1—Graves' disease	0.000369	0.0022	CbGpPWpGaD
Pseudoephedrine—TNF—Monoamine Transport—IL1B—Graves' disease	0.000364	0.00217	CbGpPWpGaD
Pseudoephedrine—TNF—IL23-mediated signaling events—IFNG—Graves' disease	0.000363	0.00216	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Monoamine Transport—IL1B—Graves' disease	0.000362	0.00216	CbGpPWpGaD
Pseudoephedrine—TNF—Downstream signaling in naïve CD8+ T cells—FASLG—Graves' disease	0.000361	0.00215	CbGpPWpGaD
Pseudoephedrine—TNF—Toll-like Receptor Signaling Pathway—CD40—Graves' disease	0.000358	0.00213	CbGpPWpGaD
Pseudoephedrine—ADRB1—G alpha (s) signalling events—TSHR—Graves' disease	0.000357	0.00213	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—HLA-DQB1—Graves' disease	0.000357	0.00212	CbGpPWpGaD
Pseudoephedrine—IL2—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000354	0.00211	CbGpPWpGaD
Pseudoephedrine—TNF—IL23-mediated signaling events—CD4—Graves' disease	0.000351	0.00209	CbGpPWpGaD
Pseudoephedrine—ADRB2—G alpha (s) signalling events—TSHR—Graves' disease	0.000349	0.00208	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—HLA-DQB1—Graves' disease	0.000348	0.00207	CbGpPWpGaD
Pseudoephedrine—TNF—Downstream signaling in naïve CD8+ T cells—IL2RA—Graves' disease	0.000347	0.00206	CbGpPWpGaD
Pseudoephedrine—IL2—Allograft Rejection—TNF—Graves' disease	0.000344	0.00205	CbGpPWpGaD
Pseudoephedrine—IL2—Spinal Cord Injury—IL1B—Graves' disease	0.000344	0.00205	CbGpPWpGaD
Pseudoephedrine—TNF—Downstream signaling in naïve CD8+ T cells—HLA-A—Graves' disease	0.000343	0.00204	CbGpPWpGaD
Pseudoephedrine—TNF—IL23-mediated signaling events—IL1B—Graves' disease	0.000324	0.00193	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Monoamine Transport—IL1B—Graves' disease	0.000321	0.00191	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—HLA-B—Graves' disease	0.00032	0.00191	CbGpPWpGaD
Pseudoephedrine—TNF—Toll-like Receptor Signaling Pathway—CXCL10—Graves' disease	0.00032	0.00191	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—FASLG—Graves' disease	0.000313	0.00186	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—HLA-B—Graves' disease	0.000313	0.00186	CbGpPWpGaD
Pseudoephedrine—MAOA—Neuronal System—GABRA3—Graves' disease	0.000311	0.00185	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—IL1B—Graves' disease	0.000307	0.00183	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Monoamine Transport—TNF—Graves' disease	0.000306	0.00182	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor Pathway—IFNG—Graves' disease	0.000305	0.00182	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—FAS—Graves' disease	0.000302	0.0018	CbGpPWpGaD
Pseudoephedrine—TNF—Alzheimers Disease—FAS—Graves' disease	0.000302	0.0018	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—ICAM1—Graves' disease	0.0003	0.00179	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—IL2RA—Graves' disease	0.0003	0.00179	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—FASLG—Graves' disease	0.000298	0.00177	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—HLA-A—Graves' disease	0.000297	0.00177	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—IL2RA—Graves' disease	0.000293	0.00174	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—HLA-E—Graves' disease	0.000291	0.00173	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—HLA-A—Graves' disease	0.00029	0.00173	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Neuronal System—GABRA3—Graves' disease	0.000289	0.00172	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—FAS—Graves' disease	0.000287	0.00171	CbGpPWpGaD
Pseudoephedrine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.000285	0.0017	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—CXCL10—Graves' disease	0.000285	0.0017	CbGpPWpGaD
Pseudoephedrine—TNF—Vitamin B12 Metabolism—IFNG—Graves' disease	0.000281	0.00167	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—CD40—Graves' disease	0.00028	0.00166	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor Pathway—IL1B—Graves' disease	0.000272	0.00162	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—HLA-DRB1—Graves' disease	0.000271	0.00161	CbGpPWpGaD
Pseudoephedrine—TNF—TGF-beta Receptor Signaling—IFNG—Graves' disease	0.000268	0.0016	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—HLA-DRB1—Graves' disease	0.000265	0.00158	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Monoamine Transport—TNF—Graves' disease	0.000263	0.00156	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—B3GNT2—Graves' disease	0.000255	0.00152	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—ICAM1—Graves' disease	0.000254	0.00151	CbGpPWpGaD
Pseudoephedrine—TNF—Vitamin B12 Metabolism—IL1B—Graves' disease	0.000251	0.00149	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—CXCL10—Graves' disease	0.00025	0.00149	CbGpPWpGaD
Pseudoephedrine—IL2—Spinal Cord Injury—TNF—Graves' disease	0.00025	0.00149	CbGpPWpGaD
Pseudoephedrine—TNF—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000239	0.00142	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—TSHR—Graves' disease	0.000234	0.00139	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Monoamine Transport—TNF—Graves' disease	0.000233	0.00139	CbGpPWpGaD
Pseudoephedrine—TNF—Downstream signaling in naïve CD8+ T cells—IFNG—Graves' disease	0.000229	0.00136	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—IFNG—Graves' disease	0.000229	0.00136	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—TNF—Graves' disease	0.000223	0.00133	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IFIH1—Graves' disease	0.000215	0.00128	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—TSHR—Graves' disease	0.000212	0.00126	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—HLA-B—Graves' disease	0.000207	0.00123	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—IL1B—Graves' disease	0.000204	0.00121	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—FAS—Graves' disease	0.000203	0.00121	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—IFNG—Graves' disease	0.000198	0.00118	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—IFNG—Graves' disease	0.000193	0.00115	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—ICAM1—Graves' disease	0.000189	0.00112	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—IL2RA—Graves' disease	0.000183	0.00109	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—FASLG—Graves' disease	0.000183	0.00109	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IFIH1—Graves' disease	0.000182	0.00108	CbGpPWpGaD
Pseudoephedrine—TNF—Selenium Micronutrient Network—IFNG—Graves' disease	0.000182	0.00108	CbGpPWpGaD
Pseudoephedrine—TNF—Alzheimers Disease—IL1B—Graves' disease	0.000177	0.00105	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—IL1B—Graves' disease	0.000177	0.00105	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—FAS—Graves' disease	0.000176	0.00105	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000175	0.00104	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—IL1B—Graves' disease	0.000172	0.00103	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—FASLG—Graves' disease	0.000171	0.00102	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.00017	0.00101	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HLA-E—Graves' disease	0.00017	0.00101	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000167	0.000992	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CD40—Graves' disease	0.000166	0.000986	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—FAS—Graves' disease	0.000166	0.000985	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—FAS—Graves' disease	0.000165	0.000983	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CTLA4—Graves' disease	0.000163	0.000972	CbGpPWpGaD
Pseudoephedrine—TNF—Selenium Micronutrient Network—IL1B—Graves' disease	0.000162	0.000964	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000155	0.000925	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000154	0.00092	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—CXCL10—Graves' disease	0.000151	0.000899	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000149	0.000887	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TSHR—Graves' disease	0.000148	0.000882	CbGpPWpGaD
Pseudoephedrine—TNF—Toll-like Receptor Signaling Pathway—IL1B—Graves' disease	0.000144	0.000857	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—IFNG—Graves' disease	0.000144	0.000855	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HLA-E—Graves' disease	0.000143	0.000853	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CD40—Graves' disease	0.00014	0.000834	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CTLA4—Graves' disease	0.000138	0.000822	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000138	0.00082	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—CXCL10—Graves' disease	0.000137	0.000816	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HLA-DQB1—Graves' disease	0.000134	0.0008	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—TSHR—Graves' disease	0.00013	0.000772	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—IL1B—Graves' disease	0.000128	0.000763	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000128	0.000762	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—TSHR—Graves' disease	0.000127	0.000755	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CD8A—Graves' disease	0.000126	0.000747	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TSHR—Graves' disease	0.000125	0.000746	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—CD4—Graves' disease	0.000124	0.000737	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HLA-B—Graves' disease	0.000121	0.000719	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000119	0.000706	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—IL2RA—Graves' disease	0.000115	0.000687	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HLA-DQB1—Graves' disease	0.000114	0.000677	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL2RA—Graves' disease	0.000113	0.000674	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—IL1B—Graves' disease	0.000112	0.000669	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HLA-A—Graves' disease	0.000112	0.000666	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.00011	0.000655	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000108	0.000641	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CD8A—Graves' disease	0.000106	0.000632	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—TSHR—Graves' disease	0.000105	0.000625	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—IL2RA—Graves' disease	0.000105	0.000624	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—CXCL10—Graves' disease	0.000104	0.00062	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—HLA-A—Graves' disease	0.000103	0.000615	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000102	0.00061	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HLA-DRB1—Graves' disease	0.000102	0.000609	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HLA-B—Graves' disease	0.000102	0.000608	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—ICAM1—Graves' disease	9.81e-05	0.000584	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—TSHR—Graves' disease	9.75e-05	0.00058	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—IL1B—Graves' disease	9.72e-05	0.000579	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—IL1B—Graves' disease	9.66e-05	0.000575	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CXCL10—Graves' disease	9.57e-05	0.00057	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IL2RA—Graves' disease	9.57e-05	0.00057	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HLA-A—Graves' disease	9.47e-05	0.000563	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	8.91e-05	0.00053	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HLA-DRB1—Graves' disease	8.65e-05	0.000515	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—TNF—Graves' disease	8.61e-05	0.000512	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GC—Graves' disease	8.43e-05	0.000502	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—CXCL10—Graves' disease	8.38e-05	0.000499	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	8.35e-05	0.000497	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—ICAM1—Graves' disease	8.3e-05	0.000494	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	8.27e-05	0.000493	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—CXCL10—Graves' disease	8.2e-05	0.000488	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CXCL10—Graves' disease	8.1e-05	0.000482	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IFNG—Graves' disease	7.47e-05	0.000445	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—TSHR—Graves' disease	7.33e-05	0.000436	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IL2RA—Graves' disease	7.32e-05	0.000436	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CD4—Graves' disease	7.21e-05	0.000429	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—TSHR—Graves' disease	7.17e-05	0.000427	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—TNF—Graves' disease	7.06e-05	0.00042	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CXCL10—Graves' disease	6.78e-05	0.000404	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL1B—Graves' disease	6.66e-05	0.000396	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—CD4—Graves' disease	6.66e-05	0.000396	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—TSHR—Graves' disease	6.66e-05	0.000396	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—TSHR—Graves' disease	6.51e-05	0.000388	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—B3GNT2—Graves' disease	6.39e-05	0.00038	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IFNG—Graves' disease	6.32e-05	0.000376	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CXCL10—Graves' disease	6.3e-05	0.000375	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—IL2RA—Graves' disease	6.19e-05	0.000368	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CD4—Graves' disease	6.1e-05	0.000363	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—TSHR—Graves' disease	5.93e-05	0.000353	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IL1B—Graves' disease	5.63e-05	0.000335	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GC—Graves' disease	5.63e-05	0.000335	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—TSHR—Graves' disease	5.51e-05	0.000328	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—TSHR—Graves' disease	5.39e-05	0.000321	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—TSHR—Graves' disease	5e-05	0.000298	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CXCL10—Graves' disease	4.74e-05	0.000282	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CXCL10—Graves' disease	4.63e-05	0.000276	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IL2RA—Graves' disease	4.31e-05	0.000256	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CXCL10—Graves' disease	4.3e-05	0.000256	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—B3GNT2—Graves' disease	4.27e-05	0.000254	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CXCL10—Graves' disease	4.21e-05	0.00025	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TSHR—Graves' disease	3.93e-05	0.000234	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TSHR—Graves' disease	3.85e-05	0.000229	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CXCL10—Graves' disease	3.83e-05	0.000228	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GC—Graves' disease	3.67e-05	0.000218	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—IL2RA—Graves' disease	3.62e-05	0.000216	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CXCL10—Graves' disease	3.56e-05	0.000212	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—IL2RA—Graves' disease	3.54e-05	0.000211	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CXCL10—Graves' disease	3.48e-05	0.000207	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL2RA—Graves' disease	3.29e-05	0.000196	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CXCL10—Graves' disease	3.23e-05	0.000192	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL2RA—Graves' disease	3.22e-05	0.000191	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TSHR—Graves' disease	3.18e-05	0.000189	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TSHR—Graves' disease	2.96e-05	0.000176	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—IL2RA—Graves' disease	2.93e-05	0.000174	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—B3GNT2—Graves' disease	2.78e-05	0.000165	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—IL2RA—Graves' disease	2.72e-05	0.000162	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL2RA—Graves' disease	2.66e-05	0.000158	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CXCL10—Graves' disease	2.54e-05	0.000151	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CXCL10—Graves' disease	2.49e-05	0.000148	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL2RA—Graves' disease	2.47e-05	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCL10—Graves' disease	2.06e-05	0.000122	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL2RA—Graves' disease	1.94e-05	0.000116	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCL10—Graves' disease	1.91e-05	0.000114	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL2RA—Graves' disease	1.9e-05	0.000113	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL2RA—Graves' disease	1.57e-05	9.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL2RA—Graves' disease	1.46e-05	8.69e-05	CbGpPWpGaD
